Skip to content

Clinical trials

Pulmonary Arterial Hypertension trials in Switzerland

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Pulmonary Arterial Hypertension Country / region: Switzerland Clear all

37 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20041
20071
20082
20093
20104
20111
20141
20151
20161
20173
20212
20222
20233
20241
202611

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed13
Not yet recruiting8
Unknown status6
Terminated5
Recruiting4
Active, not recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Silvia Ulrich Somaini9
University of Zurich8
Actelion6
Novartis Pharmaceuticals3
Acceleron Pharma, Inc., a wholly-owned subsidiary of Merck & Co., Inc., Rahway, NJ USA2
Bayer2
Idorsia Pharmaceuticals Ltd.1
Insmed Incorporated1
Merck Sharp & Dohme LLC1
Prof. Valérie Mc Lin1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Pulmonary Arterial Hypertension37
Hypertension, Pulmonary25
Altitude Sickness10
Hypoxia9
Familial Primary Pulmonary Hypertension2
Sleep Apnea Syndromes2
Congenital Portosystemic Shunt1
Eisenmenger Complex1
Hyperoxia1
Hypertension1

Trials

Showing 26 to 37 of 37. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.